Printer Friendly

CURATIVE TECHNOLOGIES INC. ANNOUNCES FIRST QUARTER RESULTS

 EAST SETAUKET, N.Y., May 3 /PRNewswire/ -- Curative Technologies (NASDAQ: CURE) today announced results of operations for the first quarter ended March 31, 1993.
 Total revenues for the first quarter of 1993 were a record $8.0 million, up 28 percent from $6.3 million reported in the first quarter of 1992. Net loss for the first quarter was $1,309,000, or $(0.13) per share, compared to a net loss of $285,000, or $(0.03) per share, for the first quarter of 1992.
 "We are very pleased to report strong growth in revenue with new patient flow into our Wound Care Centers(R) up 30 percent over prior year," said Russell B. Whitman, chairman, president and CEO. Furthermore, during 1993 the Wound Care Center Division signed agreements with seven hospitals to open new Wound Care Centers and Curative Wound Management Systems Division signed agreements to open two additional subacute care wound management facilities. Clinical trials for CT-102 in wound healing continue to progress with pivotal trials for diabetic ulcers underway in the U.S. and Europe. The results of a Phase 2 double blind trial for CT-102 in venous stasis ulcers which was completed in 1992 support the efficacy of our technology and we intend to seek approval to initiate pivotal trials for this indication later this year. The continued investment in Curative Wound Management Systems, an increased commitment to our clinical trials, and a reduction in our operating margins associated with the successful restructuring of our Wound Care Center Division are the principal factors accounting for the increase in our operating loss."
 Curative Technologies, Inc. is a technology driven healthcare company that has established itself as a leader in wound healing by providing a range of specialty products and services to healthcare providers through a nationwide network of Wound Care Centers. The company is also engaged in research, development, production and marketing of therapeutic products utilizing naturally occurring human growth factors.
 CURATIVE TECHNOLOGIES, INC. AND SUBSIDIARIES
 Selected Financial Information
 Condensed Consolidated Statement of Operations
 (Dollars in thousands, except per share data)
 Three Months Ended March 31, 1993 1992
 Revenue $8,001 $6,258
 Cost and expenses:
 Cost of product sales 1,665 1,138
 Research & development 1,835 1,351
 Marketing, general & administrative 6,023 4,356
 Total costs & expenses 9,523 6,845
 Loss from operations (1,522) (587)
 Interest income 174 266
 Net loss before minority interest (1,348) (321)
 Minority interest in net loss of
 consolidated subsidiary 39 36
 Net loss $(1,309) $(285)
 Net loss per common share $ (.13) $(.03)
 Weighted average common shares
 outstanding 9,902 9,875
 Condensed Consolidated Balance Sheet
 (Dollars in thousands)
 3/31/93 12/31/92
 Assets:
 Cash and cash equivalents $ 1,148 $ 736
 Marketable securities 14,386 17,773
 Other current assets 8,035 6,983
 Property and equipment (net) 3,038 2,636
 Other assets 848 946
 Total $27,455 $29,074
 Liabilities and Stockholders' Equity:
 Current liabilities $ 6,133 $ 6,364
 Long-term debt 190 202
 Other liabilities 1,022 1,069
 Stockholders' equity 20,110 21,439
 Total $27,455 $29,074
 -0- 5/3/93
 /CONTACT: John C. Prior, chief financial officer of Curative Technologies, Inc., 516-689-7000; or Anthony J. Russo, or Rhonda Chiger both of Noonan/Russo Communication, 212-979-9180, for Curative Technologies, Inc./
 (CURE)


CO: Curative Technologies, Inc. ST: New York IN: MTC SU: ERN

TS-PS -- NY012 -- 3565 05/03/93 08:34 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 3, 1993
Words:573
Previous Article:STRATEGIC MAPPING ENTERS AGREEMENT IN PRINCIPLE WITH DUN & BRADSTREET TO ACQUIRE DONNELLEY MARKETING INFORMATION SERVICES
Next Article:PIZZA HUT'S BIGFOOT TAKES A BITE OUT OF UNEMPLOYMENT; SUCCESS OF NEW PIZZA CREATES MORE THAN 50,000 NEW JOBS IN UNITED STATES
Topics:


Related Articles
CURATIVE TECHNOLOGIES ANNOUNCES FOURTH QUARTER AND YEAR END RESULTS
CURATIVE TECHNOLOGIES, INC. ANNOUNCES THIRD QUARTER RESULTS
CURATIVE TECHNOLOGIES, INC. ANNOUNCES FOURTH QUARTER AND YEAR END RESULTS
CURATIVE TECHNOLOGIES, INC. ANNOUNCES FIRST QUARTER RESULTS
CURATIVE HEALTH SERVICES ANNOUNCES THIRD QUARTER RESULTS
CURATIVE HEALTH SERVICES REPORTS FIRST QUARTER RESULTS
CURATIVE HEALTH SERVICES, INC. REPORTS SECOND QUARTER RESULTS
Curative Health Services Announces Fourth Quarter and Year End Results
Curative Health Services Reports Second Quarter Results
Curative Health Services Reports Third Quarter Results

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters